Log in to save to my catalogue

Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for no...

Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for no...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8019215

Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non–small cell lung cancer

About this item

Full title

Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non–small cell lung cancer

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2021-04, Vol.112 (4), p.1495-1505

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Nivolumab can cause interstitial lung disease (ILD), which may be fatal; however, mortality risk factors have not been identified. This postmarketing study evaluated the poor prognostic factors of ILD in nivolumab‐treated patients with non–small cell lung cancer (NSCLC) in Japan. Clinical and chest imaging findings for each ILD case were assessed b...

Alternative Titles

Full title

Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non–small cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8019215

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8019215

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.14710

How to access this item